|
|
| lomustine / Generic mfg. (28 Trials) |
|
| lomustine nanoparticle / Nanomerics (0 Trials) |
|
| lomvastomig (RG7769) / Roche (0 Trials) |
|
| Lonasen tape (blonanserin transdermal patch) / Nitto Denko, Sumitomo Pharma (0 Trials) |
|
| long acting angiostatin proteins / Bolder BioTech (0 Trials) |
|
| long acting basal insulin (INS068) / Jiangsu Hengrui Pharma (0 Trials) |
|
| long acting recombinant factor VIIa (ALT-Q2) / Alteogen (0 Trials) |
|
| long acting sunitinib maleate (GB-103) / CalciMedica (0 Trials) |
|
| long lasting IFN B (long lasting IFN-β biosimilar) / Nautilus (0 Trials) |
|
| Long-Acting 30R (recombinant human insulin biosimilar 30%/isophane insulin biosimilar 70%) / United Laboratories (0 Trials) |
|
| Long-Acting 50R (recombinant human insulin biosimilar 50%/isophane insulin biosimilar 50%) / United Laboratories (0 Trials) |
|
| long-acting azacitidine (NEX-18a) / Nanexa AB (0 Trials) |
|
| long-acting Erwinia asparaginase (JZP341) / Jazz (0 Trials) |
|
| long-acting erythropoietin (HM10760A) / Hanmi (0 Trials) |
|
| long-acting granulocyte-macrophage colony-stimulating factor (BBT-007) / Bolder BioTech (0 Trials) |
|
| long-acting growth hormone receptor antagonist / DFB Pharma (0 Trials) |
|
| long-acting injectable ivermectin / MedinCell (0 Trials) |
|
| long-acting insulin (AKS-130) / Akston (0 Trials) |
|
| long-acting interferon alpha-2a / Foshan First People's Hospital (0 Trials) |
|
| long-acting lumateperone (ITI-007 LAI) / Intra-Cellular Therapies (0 Trials) |
|
| long-acting peginterferon alpha (BBT-012) / Bolder BioTech (0 Trials) |
|
| long-lasting frataxin / Fratagene (0 Trials) |
|
| LongAte (plasma-derived liposomal factor VIII) / Recoly (0 Trials) |
|
| longer acting interferon-beta / Pfizer (0 Trials) |
|
| LongSeven (recombinant liposomal factor VIIa) / Recoly (1 Trials) |
|
| Lonhala Magnair (glycopyrrolate) / Sumitomo Pharma, Pari (0 Trials) |
|
| lonigutamab (VB421) / Pierre Fabre, ACELYRIN (0 Trials) |
|
| lonigutamab ugodotin (W0101) / Pierre Fabre, Roche (0 Trials) |
|
| lonodelestat (POL6014) / Spexis, Cold Spring Harbor Laboratory (0 Trials) |
|
| Lonquex (lipegfilgrastim biosimilar) / Teva (3 Trials) |
|
| Lonsurf (trifluridine/tipiracil) / Otsuka (125 Trials) |
|
| LOP628 / Novartis (0 Trials) |
|
| loperamide / Generic mfg. (29 Trials) |
|
| lopinavir/ritonavir / Generic mfg. (68 Trials) |
|
| Loqoa Tape (esflurbiprofen transdermal) / Taisho (0 Trials) |
|
| Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci (218 Trials) |
|
| Loramyc (miconazole muco-adhesive buccal tablet) / Valerio Therap, Sosei, GALT Pharma (0 Trials) |
|
| loratadine / Generic mfg. (28 Trials) |
|
| lorazepam / Generic mfg. (33 Trials) |
|
| lorazepam extended-release (EDG004) / Edgemont Pharma (0 Trials) |
|
| lorazepam intranasal (NRL-2) / Neurelis (0 Trials) |
|
| lorazepam intranasal (NRL-3) / Neurelis (0 Trials) |
|
| Lorbrena (lorlatinib) / Pfizer (40 Trials) |
|
| lorcaserin (EPX-200) / Paragon Biosci (0 Trials) |
|
| lorecivivint (SM04690) / Biosplice Therap, Samil Pharma (2 Trials) |
|
| lorediplon (GF-015535-00) / Ildong (0 Trials) |
|
| lorigerlimab (MGD019) / MacroGenics (0 Trials) |
|
| lornoxicam/paracetamol / Generic mfg. (0 Trials) |
|
| lorpucitinib (JNJ-64251330) / J&J (0 Trials) |
|
| lorukafusp alfa (APN301) / Apeiron Biologics (0 Trials) |
|
| lorundrostat (MT-4129) / Mineralys Therap (0 Trials) |
|
| lorvotuzumab mertansine (IMGN901) / AbbVie (0 Trials) |
|
| Lorzone (chlorzoxazone 375 mg USP) / RVL Pharma (0 Trials) |
|
| losartan / Generic mfg. (125 Trials) |
|
| losartan/ hydrochlorothiazide / Generic mfg. (4 Trials) |
|
| losartan/aldesleukin (IMM-01) / Modulate Therap (0 Trials) |
|
| losatuxizumab vedotin (ABBV-221) / AbbVie (1 Trials) |
|
| losmapimod (FTX-1821) / Fulcrum Therap (1 Trials) |
|
| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant (0 Trials) |
|
| lotamilast 1% topical gel (DMVT-501 1%) / Roivant (0 Trials) |
|
| Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%) / Bausch Health (0 Trials) |
|
| loteprednol etabonate / Generic mfg. (4 Trials) |
|
| loteprednol etabonate/brimonidine (OCU310) / Ocugen (0 Trials) |
|
| lotiglipron (PF-07081532) / Pfizer (0 Trials) |
|
| lotilaner oral (TP-05) / Tarsus Pharma (0 Trials) |
|
| lovastatin / Generic mfg. (8 Trials) |
|
| Lovaxin B (OST-HER2) / OS Therapies (1 Trials) |
|
| Lovaxin C (axalimogene filolisbac) / Ayala Pharma (4 Trials) |
|
| low dose dronabinol (THX-130) / SciSparc (0 Trials) |
|
| low dose IL-2 / Institute of Biological Medicine (0 Trials) |
|
| low molecular weight dextran sulfate (ILB) / TikoMed (0 Trials) |
|
| low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei (0 Trials) |
|
| low-dose hrIL-2 / Beijing SL Pharma (2 Trials) |
|
| loxapine film (INT0036) / IntelGenx (0 Trials) |
|
| loxapine oral / Generic mfg. (0 Trials) |
|
| loxicodegol (NKTR-181) / Nektar Therap (0 Trials) |
|
| LOXO-260 / Eli Lilly (0 Trials) |
|
| LOXO-783 / Eli Lilly (0 Trials) |
|
| LP 0067 / LEO Pharma (0 Trials) |
|
| LP 1810 / Laminar Pharma (0 Trials) |
|
| LP-108 / Lupeng Pharma (0 Trials) |
|
| LP-118 / Lupeng Pharma (0 Trials) |
|
| LP-128 / Lupeng Pharma (0 Trials) |
|
| LP-284 / Lantern Pharma (0 Trials) |
|
| Lp-PLA2 inhibitor / SciNeuro Pharma, GSK (0 Trials) |
|
| LP002 / Lepu Med (0 Trials) |
|
| LP002 / LintonPharm (0 Trials) |
|
| LP007 / Lepu Med (0 Trials) |
|
| LP010 / Lepu Med (0 Trials) |
|
| LP0200 / LEO Pharma (0 Trials) |
|
| LP10152 / Eli Lilly (0 Trials) |
|
| LP102 / LintonPharm (0 Trials) |
|
| LP143 / Lundbeck (0 Trials) |
|
| LP659 / Lundbeck (0 Trials) |
|
| LPA pathway modulators (AM-966) / BMS (0 Trials) |
|
| Lpathomab / Apollo Endosurgery (0 Trials) |
|
| LPCN 2101 / Lipocine (0 Trials) |
|
| LPCN-1029 / Lipocine (0 Trials) |
|
| LPM Leuprorelin / Soligenix (0 Trials) |
|
| LPMX-2 / LipoMedix (0 Trials) |
|
| LPMX-3 / LipoMedix (0 Trials) |
|
| LPX EWS/FL1 T1 / Gradalis (0 Trials) |
|
| LQ-031 / Novamab Biopharma (0 Trials) |
|
| LQ-102 / Shanghai Luoqi Biomedical Technology (0 Trials) |
|
| LQ001 / Novamab Biopharma (0 Trials) |
|
| LQ002 / Novamab Biopharma (0 Trials) |
|
| LQ004 / Novamab Biopharma (0 Trials) |
|
| LQ007 / Novamab Biopharma (0 Trials) |
|
| LQ008 / Novamab Biopharma (0 Trials) |
|
| LQ032 / Novamab Biopharma (0 Trials) |
|
| LQ036 / Novamab Biopharma (0 Trials) |
|
| LR-103 / Sanofi (0 Trials) |
|
| LR004-VC-MMAE / Shandong Xinhua Pharma, Chinese Academy of Medical Sciences (0 Trials) |
|
| LR02 / Laevoroc Oncology (0 Trials) |
|
| LR19023 / LG Chem (0 Trials) |
|
| LR19024 / LG Chem (0 Trials) |
|
| LR19122 / LG Chem (0 Trials) |
|
| LR19128 / LG Chem (0 Trials) |
|
| LRF & NuRD modulators / Pfizer (0 Trials) |
|
| LRRK2 & SNCA inhibitor therapeutic / NeuBase Therap (0 Trials) |
|
| LRRK2 G2019S-specific inhibitor / Acelot (0 Trials) |
|
| LRRK2 inhibitor therapeutic / Imago Pharma (0 Trials) |
|
| LRRK2 inhibitor therapeutic / Origenis (0 Trials) |
|
| LRRK2 inhibitor therapeutic / BPGbio (0 Trials) |
|
| LRRK2 inhibitors / (0 Trials) |
|
| LRX712 / Novartis (0 Trials) |
|
| LS-008 / Qianhong Bio-Pharma, Yabao Pharma (0 Trials) |
|
| LS-04 / selectION (0 Trials) |
|
| LSD1 inhibitor / BMS (0 Trials) |
|
| LSN2463359 / Eli Lilly (0 Trials) |
|
| LSP-GR1 / LifeSplice Pharma (0 Trials) |
|
| LSP-SCN8 / LifeSplice Pharma (0 Trials) |
|
| LSTA201 / Lisata Therap (0 Trials) |
|
| LstCAR019 / Chongqing Precision Biotech (0 Trials) |
|
| LSZ102 / Novartis (1 Trials) |
|
| LT-01206647 / (0 Trials) |
|
| LT-0302 / LTT Bio-Pharma (0 Trials) |
|
| LT-05 / Aileron (0 Trials) |
|
| LT-1001 / LTT Bio-Pharma, Sino Biopharm (0 Trials) |
|
| LT-1002 / LTT Bio-Pharma, Chong Kun Dang (0 Trials) |
|
| LT-171-861 / China Pharmaceutical University (0 Trials) |
|
| LT-3002 / LTT Bio-Pharma (0 Trials) |
|
| LT-4001 / LTT Bio-Pharma (0 Trials) |
|
| LT-V11 / Lion TCR (0 Trials) |
|
| LT-Z944 / (0 Trials) |
|
| LT3001 / Lumosa Therap (0 Trials) |
|
| LT5001 / Lumosa Therap (0 Trials) |
|
| LTAH4 enzyme regulators / Naegis (0 Trials) |
|
| LTBP-TGFβ1 fibrosis therapeutic / Scholar Rock (0 Trials) |
|
| LTC004 / Leto Laboratories (0 Trials) |
|
| LTI-01 / Aileron (0 Trials) |
|
| LTI-03 / Aileron (0 Trials) |
|
| LTP-O3FA / AstraZeneca (0 Trials) |
|
| LTP001 / Novartis (0 Trials) |
|
| LTSE-2578 / Structure Therap (0 Trials) |
|
| LTW980 / Novartis (0 Trials) |
|
| Lu 02-750 / Lundbeck (0 Trials) |
|
| Lu 177 ethylenedicysteine amifostine / Cell-Point (0 Trials) |
|
| Lu 177 PSMA I&T / Curium (0 Trials) |
|
| Lu 177 zalsenertant tetraxetan (177Lu-IPN01087) / AstraZeneca (0 Trials) |
|
| Lu AA-37096 / Lundbeck (0 Trials) |
|
| Lu AA44608 / Lundbeck (0 Trials) |
|
| Lu AE 04621 / Lundbeck (0 Trials) |
|
| Lu AF11167 / Lundbeck (1 Trials) |
|
| Lu AF20513 / Lundbeck, Otsuka (0 Trials) |
|
| Lu AF21934 / Lundbeck (0 Trials) |
|
| Lu AF28996 / Lundbeck (0 Trials) |
|
| Lu AF35700 / Lundbeck, Jiangsu NHWA Pharma (0 Trials) |
|
| Lu AF58786 / Lundbeck (0 Trials) |
|
| Lu AF60097 / Lundbeck, University of Copenhagen, National Institutes of Health (0 Trials) |
|
| Lu AF76432 / Lundbeck (0 Trials) |
|
| Lu AF87908 / Lundbeck (0 Trials) |
|
| Lu AF88434 / Lundbeck (0 Trials) |
|
| Lu AF90103 / Lundbeck (0 Trials) |
|
| Lu AG06479 / Lundbeck (0 Trials) |
|
| Lu AG09222 / Lundbeck (0 Trials) |
|
| Lu AG22515 / Lundbeck (0 Trials) |
|
| Lu-AF34134 / Lundbeck (0 Trials) |
|
| LUBT010 (ranibizumab biosimilar) / Lupin (0 Trials) |
|
| LuCaFab (ITM-31) / ITM Isotopen Technologien Munchen (0 Trials) |
|
| Lucanix (belagenpumatucel-L) / Activate Immunotherapy (1 Trials) |
|
| LUCAR-20S CAR-T cells / Legend Biotech (0 Trials) |
|
| LUCAR-B68 / Legend Biotech (0 Trials) |
|
| lucatumumab (CHIR 12.12) / Novartis, Xoma (0 Trials) |
|
| LucaVax (tertomotide) / GemVax & KAEL (4 Trials) |
|
| Lucemyra (lofexidine) / US WorldMeds, Stada (10 Trials) |
|
| Lucentis (ranibizumab) / Roche, Novartis (135 Trials) |
|
| lucerastat (ACT-434964) / Idorsia (0 Trials) |
|
| lucicebtide (ST101) / Sapience Therap (0 Trials) |
|
| LUCID-MS / FSD Pharma (0 Trials) |
|
| lucitanib (E 3810) / Clovis, Servier (3 Trials) |
|
| lucorafusp alfa (AK130) / Akesobio (0 Trials) |
|
| LucyTx-1209 / Lucy Therap (0 Trials) |
|
| LucyTx-1212 / Lucy Therap (0 Trials) |
|
| lufotrelvir (PF-07304814) / Pfizer (0 Trials) |
|
| Lufyllin (dyphylline) / Viatris (0 Trials) |
|
| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health (0 Trials) |
|
| lulizumab pegol (BMS-931699) / BMS (1 Trials) |
|
| LuLym-T (autologous activated lymphocytes) / Lujia Biomedical (0 Trials) |
|
| lumacaftor (VX-809) / Vertex (1 Trials) |
|
|